Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Can a 6-minute Walking or Resting Break Improve Executive Function in Gamers.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04674436
Recruitment Status : Active, not recruiting
First Posted : December 19, 2020
Last Update Posted : January 6, 2021
Sponsor:
Information provided by (Responsible Party):
Joanne DiFrancisco-Donoghue, New York Institute of Technology

Brief Summary:
This study will ask ranked first person shooters in esports to participate on three separate days from their home computer to test executive function prior tp play and following two hours of play. One testing day will incorporate a 6 minute walk break, another day will incorporate a 6 minute rest break, and the third day will be continuous play. Executive tests will be administered electronically prior to game play and post game play.

Condition or disease Intervention/treatment Phase
Sedentary Behavior Behavioral: Walking Not Applicable

Detailed Description:

A ranked first person shooter player will play for two hours each session, and on separate days will take a 6 minute walking break or a 6 minute resting break within 2 hours of game play. This study is virtual and you may play from your regular home gaming computer. The third day will be continuous play.

The study will take place on 3 separate days. Preferably 2 -3 days in -between testing days.

  • Participants will sign an electronic consent form to sign and agree to participate. It will explain the study in detail.
  • Participants will then be asked to take two executive function tests online. These test will be sent electronically through email. This is for practice. These tests take approximately 6-7 minutes.
  • We will schedule one day where the participant will play a first -person shooter game. Prior to playing the participants will be take to take the two executive function tests.
  • On one day the participant will be asked to stop after the first hour (they will be allowed to finish the test) they will either walk for 6 minutes near their computer or rest for 6 minutes. Participants will be contacted through cell phones or discord.
  • Game play will resume normally for another hour. When that hour is completed the participant will be asked to take the two online tests again.
  • This will be 2 days. The third day the participant will take the online tests and play continuous for 2 hours with no break and then repeat the online tests.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 29 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Can a 6-minute Walking or Resting Break Improve Executive Function and Gaming
Actual Study Start Date : July 24, 2020
Estimated Primary Completion Date : February 24, 2021
Estimated Study Completion Date : February 25, 2021

Arm Intervention/treatment
Experimental: 6 minute walking break
Participants will walk casually for 6 minutes following one hour of game play, then continue play for one more hour.
Behavioral: Walking
6 minute casual walk

Experimental: 6 minute rest break
Participants will rest supine for 6 minutes following one hour of game play, then continue play for one more hour.
Behavioral: Walking
6 minute casual walk

No Intervention: Continuous play
Participants will play continuous for 2 hours.



Primary Outcome Measures :
  1. Executive Function [ Time Frame: 2 hours ]
    The primary purpose of this study is to evaluate executive function changes following a 6-minute walking break to a 6 minute resting break in competitive esport players following 60 minutes of prolonged play



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 25 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:1. Women or men 18-25 years of age 2. Play first-person shooter games with a ranking of "gold" or higher (self reported).

-

Exclusion Criteria:1. Any participants that do not have a competitive ranking 2. Any participants that are colorblind (self reported) 3. Any participants that have sustained previous hand injuries within the last year, or suffer from chronic wrist pain.

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04674436


Locations
Layout table for location information
United States, New York
New York Institute of Technology College of Osteopathic Medicine
Old Westbury, New York, United States, 11568
New York Institute of Technology
Old Westbury, New York, United States, 11758
Sponsors and Collaborators
New York Institute of Technology
Investigators
Layout table for investigator information
Principal Investigator: Joanne Donoghue New York Institute of Technology
Layout table for additonal information
Responsible Party: Joanne DiFrancisco-Donoghue, Associate Professor, New York Institute of Technology
ClinicalTrials.gov Identifier: NCT04674436    
Other Study ID Numbers: BHS-1566
First Posted: December 19, 2020    Key Record Dates
Last Update Posted: January 6, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No